Parker Institute For Cancer Immunotherapy
90% goes to programs $0 to raise $100 Strong reserves Declining revenue
Parker Institute For Cancer Immunotherapy is a 501(c)(3) organization based in San Francisco, California, registered in 2015, with $66,947,169 in FY2024 revenue. CharityIndex grades it A, and it directs about 90% of spending to programs.
1 Letterman Dr Ste D3500, San Francisco, CA, 94129 EIN 47-3355381 Since 2015
Revenue (FY2024)
$66.9M
▲ 182.9% vs prior year
Health median: $840K
Expenses (FY2024)
$54.5M
Net assets
$185.4M
Employees
26
CharityIndex rating
One independent A+ to F grade from four published criteria, each scored separately from IRS filings and combined by weight.
A
AProgram efficiency40% of the rating90% to programs · $0 to raise $100
Measures how much of every dollar spent actually reaches programs, plus what it costs to raise $100 of donations. The worse of the two measures sets the letter (85%+ to programs is an A; under $15 to raise $100 is an A), averaged over the three most recent filings. For Parker Institute For Cancer Immunotherapy: 90% to programs · $0 to raise $100 earns a A on this criterion. See the exact thresholds →
AFinancial health25% of the rating41 mo reserves · +19% margin
Measures whether the organization is built to last: how many months its reserves would cover expenses (3+ months earns an A-range score, but hoarding 5+ years of budget is capped) and whether it runs a surplus or a deficit. For Parker Institute For Cancer Immunotherapy: 41 mo reserves · +19% margin earns a A on this criterion. See the exact thresholds →
A+Governance25% of the rating6 of 6 checks met
Checks how the organization is run, from its own Form 990: an independent board majority, a board of five or more, conflict-of-interest, whistleblower and document-retention policies, and independently audited financials. The share of disclosed checks that pass sets the letter. For Parker Institute For Cancer Immunotherapy: 6 of 6 checks met earns a A+ on this criterion. See the exact thresholds →
ATransparency10% of the rating4 of 5 disclosure signals
Counts five disclosure signals: a recent filing, a mission statement, program descriptions, a listed website, and the full expense breakdown. More disclosure, better letter. For Parker Institute For Cancer Immunotherapy: 4 of 5 disclosure signals earns a A on this criterion. See the exact thresholds →
Show this grade on your website
A live seal — it updates automatically when the grade changes and links donors to this verified profile.
Mission
See schedule o
Contact & location
- Address
- 1 Letterman Dr Ste D3500, San Francisco, CA, 94129
- City
- San Francisco
- State
- California
- Category
- Health Care
- Subcategory
- Support Foundations & Fundraising
- Phone
- …
- Website
- …
Financial trends
Revenue declined from $73.5M (FY2015) to $66.9M (FY2024) across 10 reported years.
Financial snapshot
Financial health & position (FY2024)
Liabilities $38.4MNet assets $185.4M
Operating margin
18.6%
Revenue exceeded expenses in the latest fiscal year.
Total assets
$223.9M
Total liabilities
$38.4M
Net assets
$185.4M
Salaries & benefits
$10.4M
19% of expenses
Board members
16
16 independent
Financials by year
| Fiscal year | Revenue | Expenses | Net assets | Total assets | Form |
|---|---|---|---|---|---|
| 2024 | $66,947,169▲183% | $54,471,034▲27.0% | $185,438,438▼8.3% | $223,870,654▼12.2% | 990 |
| 2023 | $23,662,636▼27.8% | $42,903,351▼31.1% | $202,213,973▼19.0% | $255,027,743▼17.0% | 990 |
| 2022 | $32,769,137▼80.8% | $62,241,652▲18.2% | $249,519,391▼23.8% | $307,154,607▼19.3% | 990 |
| 2021 | $170,996,190▲159% | $52,643,221▼24.6% | $327,532,401▲126% | $380,437,987▲149% | 990 |
| 2020 | $66,027,113▼59.4% | $69,855,756▼10.4% | $144,770,423▼2.6% | $152,630,223▼4.2% | 990 |
| 2019 | $162,648,564▲43.4% | $77,964,615▲17.8% | $148,599,066▲132% | $159,252,481▲133% | 990 |
| 2018 | $113,439,151▲72.0% | $66,202,166▲21.1% | $63,915,117▲280% | $68,405,361▲287% | 990 |
| 2017 | $65,939,195▲65.3% | $54,685,666▲39.8% | $16,828,632▲210% | $17,668,982▲190% | 990 |
| 2016 | $39,900,210▼45.7% | $39,104,869▼43.5% | $5,424,603▲17.2% | $6,100,956▲17.2% | 990 |
| 2015 | $73,509,764 | $69,207,119 | $4,629,262 | $5,207,689 | 990 |
Original Form 990 PDFs (the Form column) are served by ProPublica Nonprofit Explorer, as filed with the IRS. Create a free account to download the CSV report.
Leadership & compensation (FY2024)
Highest-paid: John Connolly Phd — $855,710 (1.57% of total expenses)
| Name | Title | Hours/week | Compensation |
|---|---|---|---|
| John Connolly Phd | Chief Scientific Officer | 40 | $855,710 |
| Kevin Marks | Chief Legal Officer | 40 | $840,863 |
| Ute Dugan Md | Chief Med. Officer Thru 6/24 | 20 | $715,023 |
| Shane Corcoran | Senior Vp, Strat. Ops. & Comms | 40 | $669,429 |
| Tarak Mody | Chief Business Officer | 40 | $632,310 |
| Sara Coblin | Sr Vp Finance & Admin. | 40 | $564,812 |
| Marko Spasic | Sr Medical Dir, Head of Med | 40 | $418,090 |
| Christen Dipetrillo | Head of Intellectual Property | 40 | $354,287 |
| Ben Horowitz | Director | 1 | — |
| Bob Hugin | Director | 1 | — |
| Bob Nelsen | Director | 1 | — |
| Bob Pittman | Director | 1 | — |
| Bruce Parker Phd | Director | 1 | — |
| Eric Esrailian Md Mph | Director | 1 | — |
| Jeff Huber | Director | 1 | — |
| Jeffrey A Bluestone Phd | Vice Chair & Director | 1 | — |
| Margo Georgiadis | Director | 1 | — |
| Michael Polansky | Executive Vp & Director | 5 | — |
| Ramy Ibrahim Md | Director | 1 | — |
| Reed Jobs | Director | 1 | — |
Top vendors & contractors (FY2024)
| Contractor | Services | Paid |
|---|---|---|
| Stanford University | Patent & License Exp | $1,345,434 |
| Regents of Univ of Cal San Franc | Patent/clinic Exp. | $1,017,795 |
| The Trustees of the Univ of PA | Patent/clinic Exp. | $653,093 |
| Regents of Univ of Cal Los Angel | Patent & License Exp | $548,409 |
| Univ of Texas Md Anderson Cancer C | Clinical Trial Exp | $454,564 |
Grants received · $428.2M total
25 grants to Parker Institute For Cancer Immunotherapy totaling $428.2M, reported by foundations on their Schedule I filings — showing the 15 most recent.
| Grantmaker | Purpose | Year | Amount |
|---|---|---|---|
| Silicon Valley Community Foundation | Health | 2024 | $40,000,000 |
| Gs Donor Advised Philanthropy Fund For Wealth Management Inc | Medical / public services | 2024 | $3,000,000 |
| American Online Giving Foundation Inc | General support | 2024 | $15,400 |
| Morgan Stanley Global Impact Funding Trust Inc | Unrestricted general support | 2024 | $5,250 |
| National Philanthropic Tr | Public, societal benefit | 2023 | $500,000 |
| Donor Advised Charitable Giving | Health | 2023 | $20,000 |
| The Aspen Institute Inc | Nonprofit fellowship participation | 2023 | $6,000 |
| The Ucla Foundation | General support | 2022 | $500,000 |
| Silicon Valley Community Foundation | Health | 2022 | $500,000 |
| Donor Advised Charitable Giving | Health | 2022 | $7,075 |
| Silicon Valley Community Foundation | Health | 2021 | $150,500,000 |
| Fidelity Investments Charitable Gift Fund | For grant recipient's exempt purposes | 2021 | $50,000 |
| Fidelity Investments Charitable Gift Fund | For grant recipient's exempt purposes | 2021 | $50,000 |
| Donor Advised Charitable Giving | Health | 2021 | $11,000 |
| Silicon Valley Community Foundation | Health | 2020 | $16,500,000 |
Grants made · $28.1M in FY2024
15 grants totaling $28.1M in FY2024. All grants made by Parker Institute For Cancer Immunotherapy →
| Recipient | Purpose | Amount |
|---|---|---|
| Dana-farber Cancer Institute | Support research in field of cancer immunotherapy | $5,425,000 |
| Weill Cornell Medicine | Support research in field of cancer immunotherapy | $4,977,086 |
| Trustees of the University of Pennsylvania | Support research in field of cancer immunotherapy | $4,666,368 |
| The Board of Trustees of the Leland Stanford Junior University | Support research in field of cancer immunotherapy | $3,582,836 |
| University of California San Francisco | Support research in field of cancer immunotherapy | $3,099,545 |
| J David Gladstone Institutes | Support research in field of cancer immunotherapy | $2,685,423 |
| Fhcrc - Hutchinson | Support research in field of cancer immunotherapy | $999,377 |
| Regents Univ of California | Support research in field of cancer immunotherapy | $750,146 |
| Washington University | Support research in field of cancer immunotherapy | $623,478 |
| The University of Texas Md Anderson Cancer Center | Support research in field of cancer immunotherapy | $377,267 |
| City of Hope | Support research in field of cancer immunotherapy | $333,333 |
| University of Pittsburgh | Support research in field of cancer immunotherapy | $256,241 |
| Memorial Sloan-kettering Cancer Center | Support research in field of cancer immunotherapy | $167,500 |
| University of Southern California | Support research in field of cancer immunotherapy | $122,117 |
| Icahn School of Medicine At Mount Sinai | Support research in field of cancer immunotherapy | $28,755 |
Similar organizations in Health
- Health
Saint Agnes Medical Foundation
Fresno, CA
$67.8M
C+annual revenue
Health
South County Community Health Center Inc
E Palo Alto, CA
$65.8M
Aannual revenue
Health
Pediatric and Family Medical Center
Los Angeles, CA
$63.5M
B+annual revenue
- Health
Complete Care Community Health Center Inc
Los Angeles, CA
$63.0M
Aannual revenue
Health
Ararat Home of Los Angeles Inc
Mission Hills, CA
$62.0M
A+annual revenue
Health
United Indian Health Services Inc
Arcata, CA
$61.7M
Aannual revenue
Health
Planned Parenthood Shasta Diablo Inc
Concord, CA
$72.4M
Aannual revenue
Health
Marin Community Clinic
Novato, CA
$72.4M
A+annual revenue
- Health
Valley Health Team Inc
San Joaquin, CA
$61.0M
Aannual revenue
Health
Lifestream Blood Bank
Sn Bernrdno, CA
$60.7M
Aannual revenue
Compare Parker Institute For Cancer Immunotherapy
Frequently asked questions
- Is Parker Institute For Cancer Immunotherapy a legitimate nonprofit?
- Yes. Parker Institute For Cancer Immunotherapy is a 501(c)(3) organization registered with the U.S. Internal Revenue Service under EIN 47-3355381, based in San Francisco, California. Donations are tax-deductible.
- What is Parker Institute For Cancer Immunotherapy's EIN?
- Parker Institute For Cancer Immunotherapy's Employer Identification Number (EIN) is 47-3355381.
- How much revenue does Parker Institute For Cancer Immunotherapy report?
- Parker Institute For Cancer Immunotherapy reported $66,947,169 in total revenue on its fiscal year 2024 IRS Form 990 filing.
- How much of Parker Institute For Cancer Immunotherapy's spending goes to programs?
- Parker Institute For Cancer Immunotherapy spends about 90% of its total expenses on programs, based on its latest IRS Form 990.
- What financial grade does Parker Institute For Cancer Immunotherapy have?
- CharityIndex grades Parker Institute For Cancer Immunotherapy A, based on program efficiency and fundraising cost.
- How much does Parker Institute For Cancer Immunotherapy's highest-paid employee make?
- The highest reported compensation on Parker Institute For Cancer Immunotherapy's latest Form 990 is $855,710, paid to John Connolly Phd (Chief Scientific Officer).
More nonprofits in San Francisco
Explore more
Data for Parker Institute For Cancer Immunotherapy (EIN 47-3355381) comes from the IRS Business Master File and e-filed Form 990 returns, via CharityIndex. Figures reflect what the organization reported to the IRS for each fiscal year.